Lara Gil Melgosa

Ms. Lara Gil Melgosa

Clinica Universidad de Navarra
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 December 2021 in Biomedicines
Verified
Journal Article
Open access
PDF file
LMLara Gil Melgosa
Lara Gil Melgosa
JGJorge Grasa
Jorge Grasa
AUAinhoa Urbiola
Ainhoa Urbiola
RLRafael Llombart-Blanco
Rafael Llombart-Blanco
MRMiguel Susaeta Ruiz
Miguel Susaeta Ruiz
APAna Pérez
Ana Pérez
Achilles tendon rupture is a frequent injury with an increasing incidence. After clinical surgical repair, aimed at suturing the tendon stumps back into their original position, the repaired Achilles tendon is often plastically deformed and mechanically less strong than the pre-injured tissue, with muscle fatty degeneration contributing to function loss. Despite clinical outcomes, pre-clinical research has mainly focused on tendon structural repair, with a lack of knowledge regarding injury progression from tendon to muscle and its consequences on muscle degenerative/regenerative processes and function. Here, we characterize the morphological changes in the tendon, the myotendinous junction and muscle belly in a mouse model of Achilles tendon complete rupture, finding cellular and fatty infiltration, fibrotic tissue accumulation, muscle stem cell decline and collagen fiber disorganization. We use novel imaging technologies to accurately relate structural alterations in tendon fibers to pathological changes, which further explain the loss of muscle mechanical function after tendon rupture. The treatment of tendon injuries remains a challenge for orthopedics. Thus, the main goal of this study is to bridge the gap between clinicians’ knowledge and research to address the underlying pathophysiology of ruptured Achilles tendon and its consequences in the gastrocnemius. Such studies are necessary if current practices in regenerative medicine for Achilles tendon ruptures are to be improved.

1 October 2020 in The Knee
Verified
Journal Article
Closed access
LMLara Gil Melgosa
Lara Gil Melgosa
AVAndrés Valentí
Andrés Valentí
ÁSÁlvaro Suárez
Álvaro Suárez
VMVerónica Montiel
Verónica Montiel

15 April 2024 in Bone & Joint Research
Verified
Journal Article
Open access
PDF file
LMLara Gil Melgosa
Lara Gil Melgosa
RLRafael Llombart-Blanco
Rafael Llombart-Blanco
LELeire Extramiana
Leire Extramiana
ILIsabel Lacave
Isabel Lacave
GAGloria Abizanda
Gloria Abizanda
APAna Pérez
Ana Pérez
Aims: Rotator cuff (RC) injuries are characterized by tendon rupture, muscle atrophy, retraction, and fatty infiltration, which increase injury severity and jeopardize adequate tendon repair. Epigenetic drugs, such as histone deacetylase inhibitors (HDACis), possess the capacity to redefine the molecular signature of cells, and they may have the potential to inhibit the transformation of the fibro-adipogenic progenitors (FAPs) within the skeletal muscle into adipocyte-like cells, concurrently enhancing the myogenic potential of the satellite cells.Methods: HDACis were added to FAPs and satellite cell cultures isolated from mice. The HDACi vorinostat was additionally administered into a RC injury animal model. Histological analysis was carried out on the isolated supra- and infraspinatus muscles to assess vorinostat anti-muscle degeneration potential.Results: Vorinostat, a HDACi compound, blocked the adipogenic transformation of muscle-associated FAPs in culture, promoting myogenic progression of the satellite cells. Furthermore, it protected muscle from degeneration after acute RC in mice in the earlier muscle degenerative stage after tenotomy.Conclusion: The HDACi vorinostat may be a candidate to prevent early muscular degeneration after RC injury.Cite this article: Bone Joint Res 2024;13(4):169–183.

1 November 2023 in Revista Iberoamericana de Cirugía de la Mano
Verified
Journal Article
Open access
PDF file
ÁAÁlvaro Suárez-López del Amo
Álvaro Suárez-López del Amo
LOLaura Olhas-Ortiz
Laura Olhas-Ortiz
LMLara Gil Melgosa
Lara Gil Melgosa
IMIsabel Martínez-Burgos
Isabel Martínez-Burgos
SPSamuel Pajares-Cabanillas
Samuel Pajares-Cabanillas
Resumen: Introducción Las prótesis trapeciometacarpianas son implantadas desde hace más de 50 años. Entre sus complicaciones, destacan la posibilidad de osteolisis, aflojamiento o luxación. Con el fin de disminuir el riesgo de luxación, se desarrollaron las prótesis trapeciometacarpianas de doble movilidad. Material y Métodos Se analizaron 66 casos de prótesis trapeciometacarpiana de doble movilidad intervenidos entre 2019 y 2022, y se evaluaron los resultados de funcionalidad, movilidad, dolor y aparición de complicaciones. Resultados El 76.7% fueron mujeres y la edad media de 62.4 años. El dolor medido en escala EVA disminuyó de 8.1 preoperatorio a 1.5 postoperatorio. En el 92.6% de los pacientes, el índice de Kapandji al mes de la cirugía se encontraba entre 9 y 10. Además, el QuickDASH disminuyó de 46.2 a 9.8. Encontramos en el primer mes tras la cirugía dos casos de aflojamiento de cotilo y una fractura de trapecio. Desde el primer mes hasta cumplir el año, tuvimos un caso de aflojamiento de vástago. Estas complicaciones requirieron tratamiento quirúrgico de revisión. No observamos ningún caso de luxación. Conclusiones La prótesis trapeciometacarpiana de doble movilidad es una opción quirúrgica con buen resultado funcional, de movilidad y supervivencia para pacientes con rizartrosis candidatos a cirugía.